| Listed below are the speakers who have accepted the offer. |
| Speaker |
Title |
| Carlos Baena-Cagnani |
The allergy epidemic still on the rise in the developing world?
|
| Hazel Dockrell |
Towards correlates of protection for TB vaccine trials - the BCG story
|
| Tom Harrison |
Immunology of cryptococcal infection: the effect of HIV
|
| Tariro Makadzange |
Early vs delayed ART in the treatment of cryptococcal meningitis
|
| Kevin Marsh |
Who is immune to malaria, and how do we know?
|
| Andrew McMichael |
HIV Vaccine Strategies
|
| Cornelis Melief |
Immunotherapy of established lesions induced by high risk papilloma viruses
|
| Narinder Mehra |
Genetic Basis of HIV-1 Transmission, Resistance and Disease
|
| Seppo Meri |
Complement and autoimmunity
|
| Nikos Papadopoulos |
Allergy as a viral immunodeficiency
|
| Sergio Romagnani |
Regulatory mechanisms of allergic inflammation
|
| Yehuda Schoenfeld |
Autoantibodies: predictive, pathogenic and protective
|
| Elopy Sibanda |
Allergic diseases in HIV immunocompromised patients
|
| Rudi Valenta |
Immunological mechanisms in IgE-mediated allergy
|
| Hartmut Wekerle |
Immune reactivity in the brain
|
| Marita Troye-Blomberg |
Will the Pf parasite affect the uptake of MTB?
|
| Anna-Lise Williamson |
Development of candidate HIV-1 subtype C vaccines for Southern Africa
|
| Stefan Kaufmann |
Novel vaccination strategies against tuberculosis
|
| Ed Janoff |
HIV and mucosal immunity
|
| Tom Campbell |
Seroprevalence and Risk Factors for HHV-8 Infection in Zimbabwe
|
| Clive Gray |
T cell Immunity in TB and HIV co-infected individuals
|
| Liz Connick |
Immune Reconstitution Inflammatory Syndromes in the Context of Antiretroviral Therapy
|
| Carolyn Williamson |
Characterisation of HIV-1 subtype C transmitted virus and evidence of early immune escape
|
| Mo Daha |
The role of complement in innate defense against pathogens
|
| Bartholomew Akanmori |
Immunopathology associated with acute childhood malaria
|
| Jorge Kalil |
Development of a vaccine against rheumatic fever
|
| James Hakim |
Acute HIV infection: strategies to develop a cohort in Zimbabwe
|
| Lynn Zijenah |
Longterm immunologic and virologic follow-up of Zimbabwean patients on generic ARVs
|
| Tom Kariuki |
Towards the develoment of a Schistosomiasis vaccine: lessons from the baboon model
|
| David Katzenstein |
"A Modest Proposal": examining the activity of candidate HIV vaccines in infected individuals
|
| Peter Iliff |
HIV and infant feeding
|
| Job Bwayo |
DNA/Adenovirus 5 phase I HIV vaccine trial
|
| Marianne van Hage |
Future prospects in immunotherapy
|
| Jorge Gavilondo |
Cancer therapeutic vaccines: forcing the immune system back to work?"
|
| Lovemore Gwanzura |
PCP in Africa
|
| Margaret Borok |
A 48 week Efficacy and Safety Analysis of Treatment of AIDS-KS with co-formulated ABC/3TC/ZDV in Zimbabwe
|
| Vu Tan Trao |
Progress in the detection of H5N1 influenza virus: experience from Vietnam
|
| Anthony Butterworth |
Schistosomiasis and HIV
|
| Robert Tweyongyere |
Effect on immune reponses following treatment for schistosomiasis during pregnancy
|
| Dan Barouch |
Novel Adenovirus Vector-Based Vaccines for HIV-1
|
| Omo Anzala |
HIV vaccines: title to follow
|
| Harriet Mpairwe |
Effect of maternal helminth infection on infantile eczema: title to follow
|
| Bruce Walker |
Immune control of HIV: Implications for HIV vaccines
|
| Sarah Rowland-Jones |
Protective immunity in HIV infection? - lessons from HIV-2 in West Africa
|
| Lynn Morris |
Neutralizing antibody responses in acute HIV-1 subtype C infection
|
| Lars Hviid |
Mapping the human antibody response to pregnancy-associated malaria
|
| Nicholas Zavazava |
Embryonic Stem Cells in Immunotherapy
|
| Rob Wilkinson |
TB: title to follow |
